Aerie Pharmaceuticals, Inc. (AERI)
(Delayed Data from NSDQ)
$39.78 USD
+1.23 (3.19%)
Updated May 3, 2019 04:00 PM ET
After-Market: $39.78 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
AERI 39.78 +1.23(3.19%)
Will AERI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AERI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for AERI
ImmunoGen (IMGN) Q3 Loss Wider, Sales Beat, '22 View Up
Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates
AERI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zoetis' (ZTS) Lags Q3 Earnings Estimates, Lowers 2022 Guidance
The Zacks Analyst Blog Highlights SilverBow Resources, Amalgamated Financial, PHX Minerals, Richardson Electronics and Aerie Pharmaceuticals
Talaris (TALS) Down on Patient Death From Renal Transplant Study